| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.75B | 12.12B | 18.95B | 18.06B | 22.38B | 21.00B |
| Gross Profit | 10.75B | 7.77B | 9.05B | 8.84B | 11.31B | 12.89B |
| EBITDA | 4.29B | -5.29B | 3.75B | 1.30B | 10.31B | 10.99B |
| Net Income | -52.00M | -3.22B | 945.00M | -1.71B | 6.02B | 3.86B |
Balance Sheet | ||||||
| Total Assets | 198.61B | 190.04B | 204.88B | 221.75B | 253.70B | 254.09B |
| Cash, Cash Equivalents and Short-Term Investments | 13.08B | 9.72B | 11.59B | 14.65B | 23.56B | 16.67B |
| Total Debt | 16.52B | 16.85B | 19.43B | 19.96B | 36.74B | 42.17B |
| Total Liabilities | 49.56B | 47.57B | 56.67B | 66.04B | 87.32B | 90.62B |
| Stockholders Equity | 143.30B | 136.83B | 142.99B | 151.59B | 162.02B | 158.85B |
Cash Flow | ||||||
| Free Cash Flow | 5.29B | 3.60B | 1.80B | 5.83B | 2.08B | 9.89B |
| Operating Cash Flow | 5.29B | 3.83B | 2.38B | 6.18B | 2.55B | 10.27B |
| Investing Cash Flow | -1.65B | -2.59B | -3.55B | 4.31B | 11.31B | -14.22B |
| Financing Cash Flow | -1.17B | -3.72B | -1.75B | -17.55B | -7.41B | -5.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$153.85B | 12.36 | 2.75% | 4.33% | 9.72% | -26.47% | |
67 Neutral | HK$108.88B | 15.34 | 2.41% | 5.62% | -0.48% | -13.78% | |
66 Neutral | HK$198.95B | 3.72 | 9.47% | 5.18% | 14.40% | -2.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$68.09B | 1,328.75 | 0.03% | 1.76% | -39.77% | 97.82% | |
59 Neutral | HK$130.24B | 4.03 | 3.63% | 4.54% | -9.54% | -38.16% | |
49 Neutral | HK$51.30B | -0.95 | -23.88% | ― | -28.36% | -206.13% |